Insights from leading international and Australian experts in ophthalmology.

 

 

Brolucizumab Update-Presented by Dr Sophia Zagora

Please join Retinal and Uveitis specialist Dr Sophia Zagora as she takes the viewer through the journey of brolucizumab to date including an update on post marketing surveillance of Brolucizumab since the USA launch in October 2019.

AU-13161

Vision: Real world perspectives

International ophthalmology expert Prof. Frank Holz discusses safety insights, real world experience with Beovu and treatment for wet AMD.
 

AU-13284

 


 

Beovu Treatment Journey

Overall, how does Beovu® (brolucizumab) change the treatment journey for wet AMD paitents and their caregivers?

AU-13272

Switching Considerations

When do you consider switching your patients to Beovu® (brolucizumab)?
 

AU-13271

 


 

Beovu and other aVEGFs

What differentiates Beovu® (brolucizumab) from existing anti-VEGFs?

AU-13268

Consenting Patients

What key points do you disucss with your patients when counselling them on starting treatment with Beovu® (brolucizumab)?

AU-13269


 
 

×

Medical Information Request